Search This Blog

Friday, July 26, 2013

CHMP Confirms Prior Opinion Regarding Marketing Authorization in Europe for Pfizer’s XELJANZ® (tofacitinib citrate) | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutical company

CHMP Confirms Prior Opinion Regarding Marketing Authorization in Europe for Pfizer’s XELJANZ® (tofacitinib citrate) | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutical company

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.